stage

Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)

LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies inspired by genetic resilience, today…

2 months ago

NYSE Content Advisory: NYSE, Money20/20, FINTECH.TV, and Cheddar create “Taking Stock”

NEW YORK, June 3, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE), Money20/20, FINTECH.TV, and Cheddar announced the launch of…

2 months ago